Dr. Mark Goldstein, MD
- Part D claims, 2022
- 14
- Clinical trials
- 9
- Industry payments
- $10,315
- State license
- 1
- Year NPI issued
- 2006
- Practice address
- 140 Jfk Dr, Atlantis, FL 33462-6608
- Practice phone
- Call (561) 968-6767
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Goldstein's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Mark Goldstein is a neurologist in Atlantis, Florida
Dr. Goldstein practices in Atlantis, Florida.
Dr. Goldstein's NPI, 1013952282, was assigned on June 19, 2006. Dr. Goldstein graduated from Emory School of Medicine in 1977. Dr. Goldstein holds Florida license ME41855.
- NPI
- 1013952282NPI Registry (opens in a new tab)
- NPI enumeration date
- June 19, 2006
- NPI status
- Active
- Practice phone
- (561) 968-6767
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Medical school graduation
- 1977
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Mark Goldstein's practice address is in Atlantis, Florida
Dr. Goldstein's practice address in the NPI Registry is 140 Jfk Dr, Atlantis, FL 33462-6608. The practice phone is (561) 968-6767.
- NPI Registry address140 Jfk Dr, Atlantis, FL 33462-6608Phone(561) 968-6767
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Mark Goldstein's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goldstein practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Goldstein's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Mark Goldstein is one of 1,297 neurologists in Florida
Neurology is Dr. Goldstein's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Goldstein is board certified in internal medicine by the American Board of Internal Medicine. Dr. Goldstein is licensed in Florida.
Specialties and state licenses
- Neurology, FloridaPrimary
Neurologists near Dr. Goldstein
Counts of neurologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Mark Goldstein's patients have a median age of 77
Across all payers, Dmand AI patient panel data puts Dr. Goldstein's median patient age at 77, with 39% women.
Dr. Goldstein's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 77
Patient panel by sex, all payers
- Women39%
- Men56%
Source: Dmand AI Patient Panel Data
Dr. Mark Goldstein wrote 14 Medicare Part D claims in 2022
In 2022, Dr. Goldstein wrote 14 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $19 in total drug cost.
Dr. Goldstein's most prescribed drugs by claims, 2022
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Mark Goldstein has worked on 9 clinical trials
Dmand AI links Dr. Goldstein to 9 clinical trials, 4 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Alzheimer Disease, Tauopathies and Parkinson Disease. Eli Lilly and Company sponsors the most, 4. Open Payments lists research payments to Dr. Goldstein that name 6 trials.
Conditions in Dr. Goldstein's trials
- Alzheimer Disease
- Tauopathies
- Parkinson Disease
- Parkinsonian Disorders
- Delirium
Investigators on the most trials with Dr. Goldstein
- Jerome A. Barakos, MD5 shared trials
- Mark L. Brody, MD5 shared trials
- Kristi K. George, MD5 shared trials
Recent clinical trials with Dr. Goldstein
Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease (opens in a new tab)
Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations (TEMPO-3) (opens in a new tab)
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; ClinicalTrials.gov (National Library of Medicine); and Dmand AI Research Linkage
Dr. Mark Goldstein received $10,315 in industry payments from 2016 to 2025
CMS Open Payments shows 90 general payments to Dr. Goldstein from 14 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 54% of the total. Novartis Pharmaceuticals Corporation paid the most, $2,346. It also lists 21 research payments totaling $235,292 from 2016 to 2024, naming 6 clinical trials.
General payments to Dr. Goldstein by program year, 2016 to 2025
General payments to Dr. Goldstein by kind, 2016 to 2025
- Travel and lodging$5,57654%
- Food and beverage$4,73946%
Companies that paid Dr. Goldstein the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Mark Goldstein graduated from Emory School of Medicine
Dr. Goldstein graduated from Emory School of Medicine in 1977.
- Medical school
- Board certified in internal medicine
- Board certified in neurology
Source: Dmand AI Professional Profile Data
Sources for Dr. Mark Goldstein's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab) |
| Clinical trials and co-investigators | ClinicalTrials.gov (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Mark Goldstein
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Mark Goldstein's NPI number?
Dr. Mark Goldstein's NPI number is 1013952282. It was assigned on June 19, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Mark Goldstein?
Dr. Mark Goldstein is a neurologist in Atlantis, Florida. The primary specialty in the NPI Registry is Neurology Physician (taxonomy code 2084N0400X).
Where does Dr. Mark Goldstein practice?
Dr. Goldstein practices at 140 Jfk Dr, Atlantis, FL 33462-6608.
What is Dr. Mark Goldstein's office phone number?
The practice phone on file for Dr. Goldstein is (561) 968-6767.
What is Dr. Mark Goldstein's medical license number?
Dr. Goldstein holds Florida license ME41855.
Is Dr. Mark Goldstein board certified?
Yes. Dr. Goldstein is board certified in internal medicine by the American Board of Internal Medicine.
Where did Dr. Mark Goldstein go to medical school?
Dr. Goldstein graduated from Emory School of Medicine in 1977.
What drugs does Dr. Mark Goldstein prescribe most?
In 2022 Medicare Part D data, Dr. Goldstein's most prescribed drugs by claims were Diazepam.
Has Dr. Mark Goldstein received payments from drug or device companies?
CMS Open Payments shows $10,315 in general payments to Dr. Goldstein from 14 companies from 2016 to 2025. The largest total came from Novartis Pharmaceuticals Corporation.
How long has Dr. Mark Goldstein been practicing?
Dr. Goldstein graduated from medical school in 1977, 49 years ago.
Does Dr. Mark Goldstein do research?
Dr. Goldstein has worked on 9 clinical trials.
Selling to neurology practices?
See neurologists in Florida by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card